Laurus Labs Limited
LAURUSLABS
Rang in aandelen
#1739
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Aandeelprijs
$22.83
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$12.34B
Verandering (1 dag)
0.51%
Verandering (1 jaar)
117.95%
Land
IN
Handel Laurus Labs Limited (LAURUSLABS)
Categorie
Healthcare
P/S-ratio voor Laurus Labs Limited (LAURUSLABS)
P/S-ratio op October 2026 TTM: 15.12
Volgens de meest recente financiële rapporten en aandelenkoers van Laurus Labs Limited is de huidige P/S-ratio (TTM) 15.12. Eind 2024 had het bedrijf een P/S-ratio van 4.35.
P/S-ratiohistoriek voor Laurus Labs Limited van 2013 tot 2026
P/S-ratio aan het einde van elk jaar
| Jaar | P/S-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 15.12 | 159.78% |
| 2025 | 5.82 | 33.90% |
| 2024 | 4.35 | 66.65% |
| 2023 | 2.61 | -59.76% |
| 2022 | 6.48 | 57.81% |
| 2021 | 4.11 | 226.89% |
| 2020 | 1.26 | -33.15% |
| 2019 | 1.88 | -30.33% |
| 2018 | 2.70 | 7.66% |
| 2017 | 2.50 | 13.66% |
| 2016 | 2.20 | -2.38% |
| 2015 | 2.26 | -11.20% |
| 2014 | 2.54 | -53.23% |
| 2013 | 5.44 | 0.00% |
P/S-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/S-ratio | Verschil in P/S-ratio | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -53.32% |
IN
|
